InvestorsHub Logo
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

Re: BonelessCat post# 65742

Wednesday, 02/20/2013 1:48:36 AM

Wednesday, February 20, 2013 1:48:36 AM

Post# of 146240

Because the numbers are for oncology, along with a lot of other numbers much higher.



And also a lot of numbers that are much lower, such as rheumatology.

In fact the number you got from the misquote was actually $23K as an average cost, not $26. The Tufts study said $26. Go look that one up.



So you're saying that this reviewer is *also* misquoting the study?

http://firstclinical.com/journal/2006/0612_Clinical_Operations.pdf

Because that guy gives us $26,000 per person for phase II trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News